New

Chrome Plugin Live! Redefine the way you read FinTwit šŸš€ Install Now

You have successfully sign out
Loading...
Shape
Canopy Growth Corporation
CGC
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

462M

Drug Manufacturers - Specialty & Generic

Next Earning date - 08 Nov 2024

462M

Drug Manufacturers - Specialty & Generic

Next Earning date - 08 Nov 2024

5.44USD
Shape0.53Ā ( 10.79%)
favorite-chart

Relative Strenght

99
favorite-chart

Volume Buzz

193%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

64%

Quote Panel

Shape
Updated October 27, 2024
1W 25.35 % 1M 12.86 % 3M -26.09 % 1Y 5.02 %

Key Metrics

Shape
  • Market Cap

    461.62M


  • Shares Outstanding

    84.86M


  • Share in Float

    84.10M


  • Dividende

    0


  • Earning Date

    08 Nov 2024


  • Price Target

    5.44


  • Average Volume

    3.77M


  • Beta

    1.791


  • Range

    2.755-14.92


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.canopygrowth.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

1.76x

P/S Ratio

1.11x

P/B Ratio

1.1

Debt/Equity

-261.9%

Net Margin

$-5.6

EPS

How CGC compares to sector?

P/E Ratio

Relative Strength

Shape

CGC

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$283M

Shape485%

2025-Revenue

$2.69

Shape-130%

2025-EPS

$24M

Shape-220%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

ATB Capital

initialise

Previous: Not converted

2024-06-18

Now: Sector Perform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-2.80
vsĀ -3.90

Q4.22

arrow
arrow

N/A

-3.50
vsĀ -2.20

Q1.23

arrow
arrow

N/A

-2.30
vsĀ -4.20

Q2.23

arrow
arrow

N/A

-0.40
vsĀ -7.00

Q3.23

arrow
arrow

N/A

-1.80
vsĀ -2.80

Q4.23

arrow
arrow

N/A

-1.79
vsĀ -3.50

Q1.24

arrow
arrow

N/A

-0.28
vsĀ -2.30

Q2.24

arrow
arrow

N/A

-0.37
vsĀ -0.40

Q3.24

arrow
arrow

N/A

-0.50
vsĀ -1.80

Q4.24

arrow
arrow

N/A

-0.45
vsĀ -1.79

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-10%

117.9MĀ  vsĀ 131.4M

Q4.22

arrow
arrow

-28%

101.2MĀ  vsĀ 141M

Q1.23

arrow
arrow

-22%

87.5MĀ  vsĀ 111.8M

Q2.23

arrow
arrow

-1%

108.7MĀ  vsĀ 110.1M

Q3.23

arrow
arrow

-30%

82.1MĀ  vsĀ 117.9M

Q4.23

arrow
arrow

-22%

78.5MĀ  vsĀ 101.2M

Q1.24

arrow
arrow

-39%

53.7MĀ  vsĀ 87.5M

Q2.24

arrow
arrow

-55%

48.4MĀ  vsĀ 108.7M

Q3.24

arrow
arrow

-22%

64.1MĀ  vsĀ 82.1M

Q4.24

arrow
arrow

-9%

71.6MĀ  vsĀ 78.5M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-14%

-0.14
vsĀ -1.27

Q4.22

arrow
arrow

-19%

-0.19
vsĀ -0.14

Q1.23

arrow
arrow

-85%

-0.85
vsĀ -0.19

Q2.23

arrow
arrow

-5%

-0.05
vsĀ -0.85

Q3.23

arrow
arrow

-41%

-0.41
vsĀ -0.05

Q4.23

arrow
arrow

-40%

-0.40
vsĀ -0.41

Q1.24

arrow
arrow

-18%

-0.18
vsĀ -0.40

Q2.24

arrow
arrow

-24%

-0.24
vsĀ -0.18

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

314

314
vsĀ 328

-4%

Q4.22

arrow
arrow

368

368
vsĀ 314

17%

Q1.23

arrow
arrow

345

345
vsĀ 368

-6%

Q2.23

arrow
arrow

323

323
vsĀ 345

-6%

Q3.23

arrow
arrow

329

329
vsĀ 323

2%

Q4.23

arrow
arrow

10

10
vsĀ 329

-97%

Q1.24

arrow
arrow

6

6
vsĀ 10

-40%

Q2.24

arrow
arrow

4

4
vsĀ 6

-33%

Earnings Growth

Latest News